These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3163828)

  • 41. Pharmacokinetics of felodipine in patients with impaired renal function.
    Edgar B; Regårdh CG; Attman PO; Aurell M; Herlitz H; Johnsson G
    Br J Clin Pharmacol; 1989 Jan; 27(1):67-74. PubMed ID: 2706189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Calcium antagonists in chronic renal failure. Undesirable effects on glomerular hemodynamics?].
    Mickisch O; Schmid M; Mann JF; Helder T; Bergen F; Rauterberg EW; Ritz E
    Dtsch Med Wochenschr; 1988 Oct; 113(40):1546-8. PubMed ID: 2844494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical evaluation of felodipine in patients with refractory hypertension.
    Herlitz H; Björck S; Nyberg G; Granérus G; Aurell M
    Drugs; 1987; 34 Suppl 3():151-5. PubMed ID: 3443059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hypertension in dialysis patients].
    Tagawa H
    Nihon Rinsho; 1992 May; 50 Suppl():610-5. PubMed ID: 1355139
    [No Abstract]   [Full Text] [Related]  

  • 45. Renal effects of felodipine in hypertension.
    Leonetti G; Terzoli L; Rupoli L; Gradnik R; Zanchetti A
    Drugs; 1987; 34 Suppl 3():59-66. PubMed ID: 3443065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Felodipine in combination with a beta-blocker and a diuretic in chronic treatment of patients with refractory primary hypertension.
    Andersson OK; Hedner T; Granérus G
    Drugs; 1987; 34 Suppl 3():156-60. PubMed ID: 2894974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Felodipine, a new calcium antagonist, modifies exercise-induced asthma.
    Patel KR; Peers E
    Am Rev Respir Dis; 1988 Jul; 138(1):54-6. PubMed ID: 3202400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catecholamines, renin-angiotensin-aldosterone, and cardiovascular response during exercise following acute and long-term calcium antagonism with felodipine in essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):439-44. PubMed ID: 2444797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Calcium antagonist treatment of renal hypertension--a new step on the way to optimizing hypotensive therapy].
    Galstian GM
    Ter Arkh; 1989; 61(8):138-43. PubMed ID: 2686067
    [No Abstract]   [Full Text] [Related]  

  • 50. Felodipine as a replacement for minoxidil in the treatment of severe hypertension.
    Wathen CG; MacLeod D; Tucker L; Muir AL
    Eur Heart J; 1986 Oct; 7(10):893-7. PubMed ID: 3792351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnosis of and therapy for renal hypertension].
    Suzuki H; Kanno Y
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):488-92. PubMed ID: 15052808
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of felodipine on hyperventilation-induced ischemic attacks in variant angina pectoris.
    Ardissino D; Savonitto S; Zanini P; De Servi S; Barberis P; Cavallotti G; Specchia G; Montemartini C
    Am J Cardiol; 1989 Jan; 63(1):104-7. PubMed ID: 2909138
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients.
    Leonetti G; Gradnik R; Terzoli L; Fruscio M; Rupoli L; Cuspidi C; Sampieri L; Zanchetti A
    J Cardiovasc Pharmacol; 1986; 8(6):1243-8. PubMed ID: 2434753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular-risk reduction: initial diuretic therapy compared with calcium-antagonist (felodipine) therapy for primary hypertension.
    Sudhir K; Jennings GL; Bruce A
    Med J Aust; 1989 Sep; 151(5):277-9. PubMed ID: 2671617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of calcium channel blocker and ACE inhibitor therapy on the progression of renal insufficiency.
    Zucchelli P; Zuccalà A; Borghi M; Fusaroli M; Sasdelli M; Stallone C; Sanna G; Gaggi R; Degli Esposti E; Vendramin G
    Contrib Nephrol; 1990; 81():255-63. PubMed ID: 2093506
    [No Abstract]   [Full Text] [Related]  

  • 56. Renal effects of acute and long-term treatment with felodipine in essential hypertension.
    Hulthén UL; Katzman PL
    J Hypertens; 1988 Mar; 6(3):231-7. PubMed ID: 3361121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.
    Hedner T; Elmfeldt D; Von Schenck H; Sjögren E; Smith U
    Br J Clin Pharmacol; 1987 Aug; 24(2):145-9. PubMed ID: 3304386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Nephrosclerosis: current status].
    Okamura M; Takeda T
    Nihon Rinsho; 1993 Aug; 51(8):2139-46. PubMed ID: 8411683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihypertensive and biochemical effects of the dihydropyridine felodipine in the long term treatment of moderate to severe hypertension.
    Sluiter HE; Huysman FT; Thien TA; Koene RA
    Drugs; 1987; 34 Suppl 3():186-93. PubMed ID: 3443060
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of lowering blood pressure on quality of life.
    Bulpitt CJ
    Curr Hypertens Rep; 2000 Dec; 2(6):509. PubMed ID: 11062594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.